BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11520777)

  • 21. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.
    Eastwood D; Gilmour KC; Nistala K; Meaney C; Chapel H; Sherrell Z; Webster AD; Davies EG; Jones A; Gaspar HB
    Clin Exp Immunol; 2004 Sep; 137(3):584-8. PubMed ID: 15320910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
    Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
    Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The abnormal gene in X-linked lymphoproliferative syndrome.
    Sullivan JL
    Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
    Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
    Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.
    Blackburn PR; Lin WL; Miller DA; Lorenzo-Betancor O; Edwards ES; Zimmermann MT; Farrugia LP; Freeman WD; Soto AI; Walton RL; Klee EW; Atwal PS; Abraham RS; Billadeau DD; Ross OA; Dickson DW; Meschia JF
    J Neuropathol Exp Neurol; 2019 May; 78(5):460-466. PubMed ID: 30990878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
    Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
    Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency.
    Salzer U; Hagena T; Webster DB; Grimbacher B
    Int Arch Allergy Immunol; 2008; 147(2):147-51. PubMed ID: 18520160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
    Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
    J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.
    Sharapova SO; Fedorova AS; Pashchenko OE; Vahliarskaya SS; Guryanova IE; Migas AA; Kondratenko IV; Aleinikova OV
    J Pediatr Hematol Oncol; 2017 May; 39(4):e203-e206. PubMed ID: 28267077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies].
    Schuster V; Grimm T; Kress W; Seidenspinner S; Belohradsky BH; Müller P; Kreth HW
    Klin Padiatr; 1995; 207(5):271-6. PubMed ID: 7500602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
    Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
    Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.
    Lankester AC; Visser LF; Hartwig NG; Bredius RG; Gaspar HB; van der Burg M; van Tol MJ; Gross TG; Egeler RM
    Bone Marrow Transplant; 2005 Jul; 36(2):99-105. PubMed ID: 15908972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.